Cardiff Lexington Corporation (CDIX)

Market Cap	31.85M +11,155.1%
Revenue (ttm)	11.54M +39.5%
Net Income	-6.54M
EPS	-0.95
Shares Out	15.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,101
Average Volume	3,972
Open	3.043
Previous Close	3.270
Day's Range	1.750 - 3.043
52-Week Range	1.000 - 18.690
Beta	1.83
RSI	29.23
Earnings Date	Mar 16, 2026

About Cardiff Lexington

Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstructi...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Alex Cunningham
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: CDIX

Financial Performance

In 2025, Cardiff Lexington's revenue was $11.54 million, an increase of 39.48% compared to the previous year's $8.27 million. Losses were -$6.54 million, 53.4% more than in 2024.